Novavax Inc (NVAX) Stock Price Today
Aura AI Summary
Key Stats
- $1.55BMARKET_CAP
- -VOLUME
- HealthSECTOR
- $11.19FIFTY_TWO_WEEK_HIGH
- $6.22FIFTY_TWO_WEEK_LOW
- -TYPICAL_HOLD_TIME
- $1.05BENTERPRISE_VALUE
- -DIVIDEND_YIELD
- -TRADING_ACTIVITY
Track Novavax Inc (NVAX) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Novavax Inc has traded between a low of $6.22 and a high of $11.19, highlighting its annual price range. Buy and sell Novavax Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Most Recent News
Global neonatal infant care market to reach $5.59B by 2035 with 6.21% CAGR driven by rising preterm births.
The global neonatal infant care market, valued at $3.06 billion in 2025, is projected to grow to $5.59 billion by 2035 at a CAGR of 6.21%. Growth is driven by increasing preterm births and neonatal complications like respiratory disorders and jaundic...

FDA approves Casgevy gene therapy for children 2+ with sickle cell disease and beta thalassemia
The FDA has approved Casgevy, a gene therapy using CRISPR technology, for children aged 2 and older with sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT). This therapy modifies patients' own stem cells to increase fetal hemo...

AI/R Avenue Code earns Google Gemini Enterprise competency, boosting secure AI adoption in businesses.
AI/R Avenue Code, a subsidiary of AI/R, has achieved Google's Gemini Enterprise competency, recognizing its expertise in deploying advanced AI solutions securely in enterprises. This certification highlights their strengths in security, workflow auto...
